Related references
Note: Only part of the references are listed.Growth hormone response during oral glucose tolerance test:: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index
Ayman M. Arafat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Adequacy of current postglucose GH nadir limit (< 1 μg/1) to define long-lasting remission of acromegalic disease
Cristina L. Ronchi et al.
CLINICAL ENDOCRINOLOGY (2007)
Medical progress: Acromegaly
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Quality of life in treated patients with acromegaly
Ritva Kauppinen-Makelin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly
Annamaria Colao et al.
CLINICAL ENDOCRINOLOGY (2006)
Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls
H Markkanen et al.
CLINICAL CHEMISTRY (2006)
Biochemical evaluation of disease activity after pituitary surgery in acromegaly:: a critical analysis of patients who spontaneously change disease status
AL Espinosa-de-los-Monteros et al.
CLINICAL ENDOCRINOLOGY (2006)
Remission criteria for the follow-up of patients with acromegaly
S Gullu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly
O Serri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Significance of abnormal nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels
PU Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Use of the oral glucose tolerance test to define remission in acromegaly
H Vierhapper et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Share Paper
